Application 761108
- Type
- BLA
- Sponsor
- ALEXION PHARM
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761108 | Ultomiris | ravulizumab-cwvz | 351(a) | Rx | 2026-10-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ULTOMIRIS | RAVULIZUMAB-CWVZ | INJECTABLE;INJECTION | 300MG/30ML(10MG/ML) | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ultomiris | RAVULIZUMAB | Alexion Pharmaceuticals Inc. | a9a590d9-0217-43c7-908d-e62a71279791 | 2026-10-29 | Boxed warning, Warnings, Adverse reactions | BLA761108 25682-025 25682-028 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 25682-022 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-022 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-022 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-022 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-022 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-022 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-022 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-022 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-022 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-022 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-025 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-025 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-025 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-025 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-025 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-025 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-025 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-028 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-028 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-028 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-028 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-028 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-028 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
| 25682-028 | Ultomiris | ravulizumab | Alexion Pharmaceuticals Inc. | BLA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 83600 | SUPPL | 2025-09-30 |
| 83583 | SUPPL | 2025-09-29 |
| 83582 | SUPPL | 2025-09-29 |
| 82693 | SUPPL | 2025-06-30 |
| 81421 | SUPPL | 2025-03-04 |
| 79669 | SUPPL | 2024-09-20 |
| 79664 | SUPPL | 2024-09-20 |
| 78966 | SUPPL | 2024-07-02 |
| 78949 | SUPPL | 2024-07-01 |
| 77955 | SUPPL | 2024-03-25 |
| 77954 | SUPPL | 2024-03-25 |
| 77949 | SUPPL | 2024-03-25 |
| 77948 | SUPPL | 2024-03-25 |
| 77448 | SUPPL | 2024-02-09 |
| 77440 | SUPPL | 2024-02-09 |
| 76273 | ORIG | 2023-11-03 |
| 71644 | SUPPL | 2022-07-27 |
| 71624 | SUPPL | 2022-07-25 |
| 71623 | SUPPL | 2022-07-25 |
| 70860 | SUPPL | 2022-04-29 |
| 70837 | SUPPL | 2022-04-27 |
| 70836 | SUPPL | 2022-04-27 |
| 69824 | SUPPL | 2022-01-11 |
| 69823 | SUPPL | 2022-01-10 |
| 69412 | SUPPL | 2021-11-24 |
| 67741 | SUPPL | 2021-06-08 |
| 67740 | SUPPL | 2021-06-08 |
| 67739 | SUPPL | 2021-06-08 |
| 67447 | SUPPL | 2021-05-10 |
| 67168 | SUPPL | 2021-04-23 |
| 64907 | SUPPL | 2020-10-14 |
| 64906 | SUPPL | 2020-10-14 |
| 64898 | SUPPL | 2020-10-14 |
| 62784 | SUPPL | 2020-05-01 |
| 60623 | SUPPL | 2019-10-22 |
| 60591 | SUPPL | 2019-10-18 |
| 60590 | SUPPL | 2019-10-18 |
| 57245 | ORIG | 2019-01-18 |
| 56976 | ORIG | 2018-12-21 |
| 56967 | ORIG | 2018-12-21 |
| 63241 | SUPPL | 1900-01-01 |